» Articles » PMID: 34414521

Efficacy of Periodontal Minimally Invasive Surgery with and Without Regenerative Materials for Treatment of Intrabony Defect: a Randomized Clinical Trial

Overview
Specialty Dentistry
Date 2021 Aug 20
PMID 34414521
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The minimally invasive surgical technique was modified in suture (MISTms) in this study. The trial was to determine the efficacy of MISTms with and without regenerative materials for the treatment of intrabony defect and to identify factors influencing 1-year clinical attachment level (CAL) gain.

Methods: Thirty-six patients with interdental intrabony defects were randomly assigned to MISTms (MISTms alone, 18) or MISTms plus deproteinized bovine bone mineral and collagen membrane (MISTms combined, 18). Wound healing was evaluated by early healing index (EHI) at 1, 2, 3, and 6 weeks. Probing depth (PD), CAL, gingival recession, radiographic defect depth, and distance from the base of defect to the cementoenamel junction were recorded at baseline and 1 year postoperatively. A one-year composite outcome measure based on the combination of CAL gain and post-surgery PD was evaluated. Factors influencing 1-year CAL gain were analyzed.

Results: Fifteen patients in MISTms-alone and 16 in the MISTms-combined group finished the study. The MISTms-alone group showed significantly better wound healing at 1 week. CAL significantly gained in the MISTms-alone and MISTms-combined group, with 2.53 ± 1.80 mm and 2.00 ± 1.38 mm respectively. The radiographic bone gain was 3.00 ± 1.56 mm and 3.85 ± 1.69 mm respectively. However, there were no significant differences between the two groups about 1-year outcomes. Lower EHI (optimal wound healing) and more baseline CAL positively influenced 1-year CAL gain.

Conclusions: MISTms is an effective treatment for intrabony defects. The regenerative materials do not show an additional effect on 1-year outcomes. Early wound healing and baseline CAL are factors influencing 1-year CAL gain.

Clinical Relevance: MISTms with and without regenerative materials are both effective treatments for intrabony defect.

Trial Registration: ClinicalTrials.gov Identifier: ChiCTR2100043272.

Citing Articles

A narrative review of papilla preservation techniques in clinical dentistry.

Fu Y, Zhang Z, Tang X, Su J Medicine (Baltimore). 2025; 104(3):e41033.

PMID: 39833085 PMC: 11749603. DOI: 10.1097/MD.0000000000041033.


Exploratory study on a novel minimally invasive tunnel like flap approach for orthodontic movement of dental implants.

Adly M, Cuisinier F, Adly A, Estephan E, Adly A, Bousquet P Clin Oral Investig. 2024; 28(11):595.

PMID: 39400762 DOI: 10.1007/s00784-024-05992-w.


Periodontal regenerative therapy using recombinant human fibroblast growth factor (rhFGF)-2 in combination with carbonate apatite granules or rhFGF-2 alone: 12-month randomized controlled trial.

Imamura K, Yoshida W, Seshima F, Aoki H, Yamashita K, Kitamura Y Clin Oral Investig. 2024; 28(11):574.

PMID: 39373727 DOI: 10.1007/s00784-024-05979-7.


From Basic Science to Clinical Practice: A Review of Current Periodontal/Mucogingival Regenerative Biomaterials.

De Lauretis A, Ovrebo O, Romandini M, Lyngstadaas S, Rossi F, Haugen H Adv Sci (Weinh). 2024; 11(17):e2308848.

PMID: 38380549 PMC: 11077667. DOI: 10.1002/advs.202308848.


Clinical and radiographic evaluation of Bio-Oss granules and Bio-Oss Collagen in the treatment of periodontal intrabony defects: a retrospective cohort study.

Wang J, Cui W, Zhao Y, Lei L, Li H J Appl Oral Sci. 2024; 32:e20230268.

PMID: 38198370 PMC: 11019911. DOI: 10.1590/1678-7757-2023-0268.


References
1.
Abusleme L, Hoare A, Hong B, Diaz P . Microbial signatures of health, gingivitis, and periodontitis. Periodontol 2000. 2021; 86(1):57-78. DOI: 10.1111/prd.12362. View

2.
Jakubovics N, Goodman S, Mashburn-Warren L, Stafford G, Cieplik F . The dental plaque biofilm matrix. Periodontol 2000. 2021; 86(1):32-56. PMC: 9413593. DOI: 10.1111/prd.12361. View

3.
Camelo M, Nevins M, Schenk R, Simion M, Rasperini G, Lynch S . Clinical, radiographic, and histologic evaluation of human periodontal defects treated with Bio-Oss and Bio-Gide. Int J Periodontics Restorative Dent. 2003; 18(4):321-31. View

4.
Mellonig J . Human histologic evaluation of a bovine-derived bone xenograft in the treatment of periodontal osseous defects. Int J Periodontics Restorative Dent. 2001; 20(1):19-29. View

5.
Tonetti M, Cortellini P, Lang N, Suvan J, Adriaens P, Dubravec D . Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomized controlled clinical trial. J Clin Periodontol. 2004; 31(9):770-6. DOI: 10.1111/j.1600-051X.2004.00562.x. View